Posts by cstephenson@legacymedsearch.com
Cagent Vascular Announces FDA 510(k) Clearance for Balloon Catheter
Cagent Vascular (Wayne, PA), a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces FDA 510(k) Clearance of its Serranator® PTA Serration Balloon Catheter for treating below-the-knee (BTK) lesions. The Serranator device is the first and only angioplasty balloon FDA Cleared and CE Marked that embeds serration technology into a semi-compliant balloon…
Read MoreHealthySole HOME Approved to Keep Your Home Safe From COVID-19
Researchers have proven a device using ultraviolet light technology can neutralize the COVID-19 virus and other infectious diseases on the soles of shoes by more than 99.5 percent, according to a new study. The device, called HealthySole® PLUS, is being introduced in hospitals and other settings where infection control is urgent. A home version of the…
Read MoreFDA Grants ALung Emergency Use Authorization (EUA) to the Hemolung Respiratory Assist System (RAS) for the Treatment of COVID-19
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced that the Food and Drug Administration (FDA) has granted the Company Emergency Use Authorization (EUA) designation to the Hemolung® Respiratory Assist System (RAS) for the treatment of Coronavirus Disease 2019 (COVID-19) patients. ALung…
Read MoreFDA grants Carmell Therapeutics Expedited Review for CT-101, Bone Healing Accelerant
Carmell Therapeutics, a pioneer in the development and commercialization of innovative Plasma-based Bioactive Materials (PBMs) to accelerate bone and soft tissue healing, announced that the U.S. Food and Drug Administration (FDA) last week has granted Fast Track designation for the Company’s first product, a Bone Healing Accelerant (BHA). The Fast Track designation provides the company benefits in…
Read MoreAliveCor and OMRON Announce Global Strategic Alliance for Comprehensive Remote Cardiovascular Monitoring
AliveCor, a leader in personal ECG products, and OMRON Healthcare, Co., Ltd., a global leader in personal heart health and wellness technology, today announced a global, strategic alliance that combines AliveCor’s ECG technology with industry-leading blood pressure devices from OMRON to better serve customers and expand access to remote patient care. This partnership aligns with global…
Read MoreSterilucent Granted Emergency Use Authorization to Reprocess Respirators
The U.S. Food and Drug Administration has granted Sterilucent, Inc. (Minneapolis, MN), an Emergency Use Authorization to allow the emergency use of the Sterilucent™ HC 80TT Vaporized Hydrogen Peroxide Sterilizer for decontaminating single-use compatible N95 and N95-equivalent respirators. Test results have demonstrated that filtering facepiece respirators may be reprocessed for use during the COVID-19 pandemic…
Read MoreOlympus Launches EVIS X1, its Most Advanced Endoscopy System to Date
Olympus Corporation (President: Yasuo Takeuchi) today announced the launch of EVIS X1, its most advanced endoscopy system to date. The new system is to improve outcomes from disorders of the stomach, colon, and oesophagus, as well as from bronchial diseases, by providing every endoscopist with innovative and proven tools. The launch of EVIS X1 further…
Read MoreZEUS Scientific Announces New Rapid SARS-CoV-2 Antibody Test
ZEUS Scientific announces today the submission for an Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for its rapid, in vitro diagnostic test for the qualitative detection of IgG and/or IgM antibodies to the SARS-CoV-2 (novel 2019 Coronavirus). ZEUS’s lateral flow test uses patient serum, plasma or whole blood and provides results in…
Read MoreNew Renewable Energy Agreements To Reduce Boston Scientific Carbon Footprint By Half
Boston Scientific Corporation (NYSE: BSX) has signed a virtual power purchase agreement (VPPA) that represents the largest step the company has taken to achieve its goal of global carbon neutral manufacturing and distribution by 2030. The agreement, with Clearway Energy Group, will address the electricity load for the company’s U.S. operations, which represents 45 percent of…
Read MoreBrainlab Announces CE Mark for ExacTrac Dynamic Patient Positioning and Monitoring
Brainlab, the digital medical technology company, today announced CE Mark (Conformité Européenne) approval for ExacTrac® Dynamic, the company’s next generation patient positioning and monitoring system. The new system offers never-before-seen, high-speed thermal surface tracking technology combined with an update of ExacTrac X-ray monitoring, providing advanced capabilities. New clinical workflows allow for treatment of a wide array of…
Read More